| William Chippendale, MASTERS | |
|
1516 Atwood Ave, Johnston, RI 02919-3223 | |
| (401) 553-1000 | |
| (401) 553-1143 |
| Full Name | William Chippendale |
|---|---|
| Gender | Male |
| Speciality | Counselor |
| Location | 1516 Atwood Ave, Johnston, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114247210 | NPI | - | NPPES |
| GH57134 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Chippendale, MASTERS 1516 Atwood Ave, Johnston, RI 02919-3223 Ph: (401) 553-1000 | William Chippendale, MASTERS 1516 Atwood Ave, Johnston, RI 02919-3223 Ph: (401) 553-1000 |
News Archive
In its rush to blunt public opposition to the newly enacted health reform law, the Obama administration is on a collision course with Republicans as the November midterm elections loom. On behalf of his reform agenda, President Barack Obama in recent weeks bypassed the Senate to make a "recess" appointment of a new Medicare and Medicaid administrator, Donald Berwick, while Congress was adjourned for the Independence Day holiday.
Lung cancer is the number one cause of cancer death in men and women, but huge randomized trials of thousands of patients have either failed completely or shown negligible survival differences.
A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced that a new publication from the large Women & Infants multi-center clinical study on the Sequenom Center for Molecular Medicine's (Sequenom CMM) MaterniT21 PLUS laboratory-developed test (LDT) has been published online in the peer-reviewed journal, Prenatal Diagnosis.
BioMarin Pharmaceutical Inc. today announced its program for BMN-111, a peptide therapeutic for the treatment of achondroplasia. BioMarin plans to file an IND in the fourth quarter of 2011 and to initiate a Phase 1 clinical trial by the first quarter of 2012.
› Verified 9 days ago
Michele Wilson, BACHELORS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1516 Atwood Ave, Johnston, RI 02919 Phone: 401-724-8400 Fax: 401-722-5280 | |
Laurie Thornton, MA, CAGS, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1443 Hartford Ave, Johnston, RI 02919 Phone: 401-273-8100 Fax: 401-861-8696 | |
Alexia Sanford, MA, LMHC-A Counselor Medicare: Not Enrolled in Medicare Practice Location: 1524 Atwood Ave Ste 115, Johnston, RI 02919 Phone: 401-773-3700 | |
Mrs. Rana M Dequattro, LCMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 50 Mulberry Cir, Johnston, RI 02919 Phone: 401-465-5144 Fax: 401-349-0494 | |
Courtney Hills, Counselor Medicare: Medicare Enrolled Practice Location: 8 Cady St, Johnston, RI 02919 Phone: 603-285-3163 | |
Britni J Butti, LCDP Counselor Medicare: Not Enrolled in Medicare Practice Location: 985 Plainfield St, Johnston, RI 02919 Phone: 401-946-0650 Fax: 401-946-2407 | |
Mckayla Arbige, MASTERS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1443 Hartford Ave, Johnston, RI 02919 Phone: 401-553-1000 Fax: 401-553-1043 |